CNWK DE000A1K0227 A1K022

Bericht

Schlusskurs Xetra - 20/05
1.070	EUR		0.00%

05.05.	CO.DON AG : CO.DON AG: Die Europäische Kommission erteilt unbefristete Verlängerung der EU-weiten Zulassung des Arzneimittels Spherox	DP
04.05.	CO.DON AG (VON SPHENE CAPITAL GMBH) : Buy	DP
29.04.	Co.don AG kündigt Rücktritt von Hans-B. Bauerfeind als Vorsitzender des Aufsichtsrats aus gesundheitlichen Gründen	CI

News

Andere Sprachen

Offizielle Publikationen

Branchen-News

Nachrichten in anderen Sprachen über CO.DON AG

29.04.	CO.DON AG : Chairman of the Supervisory Board resigns for health reasons
29.04.	Co.don AG Announces Resignation of Hans-B. Bauerfeind as Chairman of the Supervisory Bo..
28.03.	CO.DON AG : Spherox included on the list of pharmaceutical products reimbursed in Belgium
21.03.	CO.DON AG : CO.DON AG and JOINT OPERATIONS (UK) LLP sign contract for the distribution of ..
21.03.	Co.Don AG and Joint Operations (Uk) LLP Sign Contract for the Distribution of Spherox i..
01.03.	CO.DON AG : Recommendation to make EU marketing authorisation for Spherox valid for an unl..
25.02.	CO.DON AG : Member of the Management Board resigns as of February 28, 2022
25.02.	Co.don AG Announces Resignation of Hans-Joachim Simons as Member of the Executive Board..
27.01.	CO.DON AG (ISIN : DE 000A3E5C08 / DE000A3E5C16): Preliminary Business Figures 2021
27.01.	co.don AG Provides Consolidated Earnings Guidance for the Year 2021
25.01.	CO.DON AG : 5-year results confirm safety and effectiveness of matrix-associated autologou..
2021	CO.DON AG : Mexico's ambassador visits CO.DON AG
2021	CO.DON AG : licence agreement for product out-licensing in the Asian economic area signed
2021	CO.DON AG and ReLive Biotechnologies Co., Ltd. Sign Licence Agreement for Product Out-L..
2021	CO.DON AG (ISIN : DE 000A3E5C08 / DE000A3E5C16) – Intended product out-licensing in ..
2021	CO.DON Aktiengesellschaft Announces Intended Product Out-Licensing in the Asian Economi..
2021	Co.Don Ag Reports Earnings Results for the Half Year Ended June 30, 2021
2021	CO.DON AG : Start of routine production at the Leipzig site on time and on budget
2021	CO.DON AG announces Start of Routine Production At the Leipzig Site on Time and on Budg..
2021	CO.DON AG : GMP inspection of the higher federal authority and the Saxony state directorat..
2021	CO.DON AG : Marketing authorisation granted for Spherox in the United Kingdom
2021	Co.don Ag Announces Marketing Authorisation Granted for Spherox in the United Kingdom
2021	CO DON : Secures European Regulator's Approval Extension for Spherox
2021	CO.DON AG : EU-approved medicinal product receives vote for indication extension for use i..
2021	CO.DON AG (ISIN : EN DE000A1K0227): EU-approved medicinal product receives vote for indica..
2021	Co.don AG Receives Positive Vote of Committee for Medicinal Products for Human Use of t..
2021	Co.Don Ag Reports Earnings Results for the Full Year Ended December 31, 2020
2021	CO.DON AG : Technology transfer process gets green light from EMA
2021	Co.don AG Technology Transfer Process Gets Green Light from EMA
2021	CO.DON AG (ISIN : DE DE000A1K0227): Notice of loss pursuant to Sec. 92 (1) AktG
2021	CO DON : on our own behalf - TV reports on cartilage cell transplantation
2021	CO.DON AG (ISIN : DE DE000A1K0227): Preliminary business figures 2020
2021	Co.don AG Provides Preliminary Consolidated Earnings Guidance for the Year 2020
2020	CO.DON AG (ISIN : DE DE000A1K0227): Agreement with Bauerfeind Beteiligungsgesellschaft mbH..
2020	CO DON : Executive Board expanded to strengthen commercial activities
2020	CO.DON AG Appoints Achim Simons to Executive Board
2020	DON : reports good first quarter 2020, adjustment to preliminary figures for 2019, forcast..
2020	Co.don AG Reports Unaudited Consolidated Earnings Results for the Year Ended December 3..
2020	Co.don AG Reports Revenue Results for the First Quarter of 2020
2020	Co.don AG Provides Earnings Guidance for the Full Year 2020
2020	CO.DON AG : Preliminary figures for Q1 2020, effects of the covid-19 pandemic in financial..
2020	CO.DON AG : Adjustment of the preliminary business figures 2019
2020	Co.don AG Announces Unaudited Adjusted Preliminary Business Figures for 2019
2020	CO.DON AG : Delayed publication of financial statements, agreement on provision of additio..
2020	CO.DON AG : Repeat GMP certification successfully received for the Teltow site
2020	CO.DON AG : Restructuring program implemented
2020	CO.DON AG Adds Contract Manufacturing to its Product Portfolio
2020	DON : adds contract manufacturing to its product portfolio
2020	CO.DON AG : CO.DON AG launches new website
2020	CO.DON AG : CO.DON receives manufacturing licence for own and contract production at Leipz..
2020	CO.DON AG (ISIN : DE DE000A1K0227): Preliminary figures 2019
2020	CO.DON AG : Preliminary figures 2019
2020	Co.don Aktiengesellschaft Reports Earnings Guidance for the Year 2019
2020	CO.DON AG : Member of the Management Board Ralf M. Jakobs resigned
2020	CO.DON AG : Member of the Management Board of Ralf M. Jakobs resigned
2020	Co.don AG Announces Executive Changes
2019	CO.DON AG : CO.DON nominated by US magazine 'MedTech Outlook' for 'TOP 10 Orthopedic Solut..
2019	Co.don AG announced that it has received €5.86463 million in funding from Bauerfeind Be..
2019	CO.DON AG : CO.DON AG completes capital increase
2019	CO.DON AG : co.don Aktiengesellschaft completes capital increase
2019	CO.DON : co.don Aktiengesellschaft decides to increase share capital through rights issue ..
2019	CO.DON AG : co.don Aktiengesellschaft decides to increase share capital through rights iss..
2019	DON : Discussions on out-licensing and further cooperations
2019	CO.DON AG : Discussions on out-licensing and further cooperations
2019	DON : Negotiations on capitalization and out-licensing
2019	CO.DON AG : Negotiations on capitalization and out-licensing
2019	CO.DON AG : - First Spherox patients treated in the Netherlands
2019	CO.DON : Negotiations with Xintela on creation of joint venture to be discontinued
2019	CO.DON : Negotiations with Xintela on joint venture discontinued
2019	CO.DON AG : Negotiations with Xintela on creation of joint venture to be discontinued
2019	CO.DON AG : Negotiations with Xintela on joint venture discontinued
2019	CO.DON : successful Annual General Meeting 2019
2019	CO.DON AG : successful Annual General Meeting 2019
2019	DON : signs term sheet with BIOVIIIx for the distribution of Spherox in Italy
2019	Generium JSC Enters into Licensing Agreement with co.don AG

1 2 3 Weiter

Anstehende Termine für CO.DON AG

29.06.22

Jahreshauptversammlung

Finanzkalender des Unternehmens

Anstehende Branchentermine

26.07.22	BIOGEN INC. : Erstes Halbjahr 2022 Ergebnisveröffentlichung (geplant)
16.08.22	SAMSUNG BIOLOGICS CO.,LTD. : Erstes Halbjahr 2022 Ergebnisveröffentlichung (geplant)
17.08.22	CSL LIMITED : Jahr 2022 Ergebnisveröffentlichung
22.08.22	WUXI BIOLOGICS (CAYMAN) INC. : Erstes Halbjahr 2022 Ergebnisveröffentlichung (geplant)

Mehr Termine

Branche

Gesundheitspflege
	Pharmazie und Biotechnologie
		Pharmazie und Biotechnologie
			Pharmazeutika
				Biopharmazeutika